A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars.

Chlamydia trachomatis (Ct) comprises distinct serogroups and serovars. The present study evaluates a novel Ct amplification, detection, and genotyping method (Ct-DT assay). The Ct-DT amplification step is a multiplex broad-spectrum PCR for the cryptic plasmid and the VD2-region of ompl. The Ct-DT detection step involves a DNA enzyme immunoassay (DEIA) using probes for serogroups (group B, C, and intermediate) and the cryptic plasmid, permitting sensitive detection of 19 Ct serovars (A, B/Ba, C, D/Da, E, F, G/Ga, H, I/Ia, J, K, L1, L2/L2a, and L3) without any cross-reactivity with other Chlamydia species and pathogenic bacteria or commensal organisms of the genital tract. Ct-positive samples are analyzed by a nitrocellulose-based reverse hybridization assay (RHA) containing probes for the 19 different serovars and for the cryptic plasmid. The sensitivity of the PCR-DEIA on clinical specimen is equivalent to that of the Cobas TaqMan assay [kappa = 0.95 (95% confidence interval = 0.92 to 0.99)]. Using the RHA, 98% of the Ct-DT detection step-positive samples could be typed. Analysis of cervical swabs from Uganda and The Netherlands revealed that the most common serovars in Uganda are G/Ga (45%), E (21%), K (13%), and F (8%), and in The Netherlands serovars E (38%), F (23%), G/Ga (11%), and D/Da (7%) were most common. Thus, multiplex broad-spectrum PCR in combination with DEIA and RHA permits highly sensitive and specific detection and identification of Ct serovars.

[1]  P. Nilsson,et al.  A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. , 2007, Sexually transmitted diseases.

[2]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[3]  F. Kong,et al.  Use of PCR and Reverse Line Blot Hybridization Assay for Rapid Simultaneous Detection and Serovar Identification of Chlamydia trachomatis , 2006, Journal of Clinical Microbiology.

[4]  T. Darville Chlamydia trachomatis infections in neonates and young children. , 2005, Seminars in pediatric infectious diseases.

[5]  J. Dillner,et al.  Chlamydia trachomatis infection and persistence of human papillomavirus , 2005, International journal of cancer.

[6]  R. Peeling,et al.  Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study , 2004, International journal of cancer.

[7]  S. Morré,et al.  Combination of PCR Targeting the VD2 of omp1 and Reverse Line Blot Analysis for Typing of Urogenital Chlamydia trachomatis Serovars in Cervical Scrape Specimens , 2004, Journal of Clinical Microbiology.

[8]  Robert E. Johnson,et al.  Population-Based Genetic and Evolutionary Analysis of Chlamydia trachomatis Urogenital Strain Variation in the United States , 2004, Journal of bacteriology.

[9]  N. Muñoz,et al.  Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia. , 2003, Sexually transmitted infections.

[10]  D. Mabey,et al.  Lymphogranuloma venereum , 2002, Sexually transmitted infections.

[11]  C. Black,et al.  Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1) , 2001, Sexually transmitted infections.

[12]  J. Albert,et al.  Characterization of Chlamydia trachomatis omp1 Genotypes among Sexually Transmitted Disease Patients in Sweden , 2001, Journal of Clinical Microbiology.

[13]  Wim Quint,et al.  Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus , 1999, Journal of Clinical Microbiology.

[14]  S. Morré,et al.  Genomic Relatedness of ChlamydiaIsolates Determined by Amplified Fragment Length Polymorphism Analysis , 1999, Journal of bacteriology.

[15]  J. Schachter,et al.  Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. , 1999, Bulletin of the World Health Organization.

[16]  W. Quint,et al.  Technical Advance Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses , 1998 .

[17]  B. Van Der Pol,et al.  Identification of a Chlamydia trachomatis Serovar E Urogenital Isolate Which Lacks the Cryptic Plasmid , 1998, Infection and Immunity.

[18]  P. Piot,et al.  Global prevalence and incidence estimates of selected curable STDs. , 1998, Sexually transmitted infections.

[19]  J. Walboomers,et al.  Serotyping and Genotyping of GenitalChlamydia trachomatis Isolates Reveal Variants of Serovars Ba, G, and J as Confirmed by omp1 Nucleotide Sequence Analysis , 1998, Journal of Clinical Microbiology.

[20]  B. Munoz,et al.  Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. , 1997, The Journal of infectious diseases.

[21]  M. Comanducci,et al.  Characterization of a new isolate of Chlamydia trachomatis which lacks the common plasmid and has properties of biovar trachoma , 1997, Infection and immunity.

[22]  W. M. Mac Kenzie,et al.  Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.

[23]  A. de Vries,et al.  Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars , 1994, Journal of clinical microbiology.

[24]  R. Brunham,et al.  Chlamydia trachomatis from individuals in a sexually transmitted disease core group exhibit frequent sequence variation in the major outer membrane protein (omp1) gene. , 1994, The Journal of clinical investigation.

[25]  J. Sellors,et al.  Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids , 1993, Journal of clinical microbiology.

[26]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[27]  J. Ito,et al.  Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection , 1990, Infection and immunity.

[28]  E. Peterson,et al.  The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. , 1990, Plasmid.

[29]  J. Ito,et al.  Variation inVirulence among Oculogenital Serovars ofChlamydia trachomatis inExperimental Genital TractInfection , 1990 .

[30]  K. Holmes,et al.  Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington , 1983, Infection and immunity.